Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Rutin

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    6 result(s) found for: Rutin. Displaying page 1 of 1.
    EudraCT Number: 2004-004929-99 Sponsor Protocol Number: 6602027507 Start Date*: 2005-08-25
    Sponsor Name:Department of women's and Children's health, Uppsala University.
    Full Title: Cardiac effects of oxytocin administrated during cesarean section, signs of myocardial ischaemia.
    Medical condition: Vid kejsarsnitt upplever en del kvinnor bröstsmärtor. I studier med Holter EKG har man i 25-60% hos friska påvisat ST-sänkningar under kejsarsnitt. I en studie har man visat en höjning av Troponin ...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2021-000175-37 Sponsor Protocol Number: 2021-000175-37 Start Date*: 2021-02-09
    Sponsor Name:Karolinska Universitetssjukhuset
    Full Title: Immunological Responses after Vaccination for COVID-19 with the mRNA Vaccine Comirnaty in Immunosuppressed and Immunocompetent Individuals. An open, non-randomized , phase IV multicenter study
    Medical condition: SARS-COV-2 Infection
    Disease: Version SOC Term Classification Code Term Level
    23.0 100000004862 10084272 SARS-CoV-2 infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-005727-28 Sponsor Protocol Number: 2008-005727-28 Start Date*: 2009-12-12
    Sponsor Name:Karolinska Universitetssjukhuset
    Full Title: BK viremi efter njurtransplantation: Screening, tidig diagnostik, tidig reduktion av immunhämning samt behandling med leflunomid (Arava®)
    Medical condition: BK Virusinfektion vid Njurtransplantation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10055181 BK virus infection PT
    9.1 10023438 Kidney transplant LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-005096-12 Sponsor Protocol Number: OPRERA Start Date*: 2021-05-31
    Sponsor Name:Karolinska Universitetssjukhuset
    Full Title: Utvärdering av två kortison behandlingsstrategier hos patienter med nydiagnostiserad, tidigare obehandlad reumatoid artrit: en randomiserad, öppen, non-inferiority klinisk studie
    Medical condition: Rheumatoid arthritis
    Disease: Version SOC Term Classification Code Term Level
    23.1 10028395 - Musculoskeletal and connective tissue disorders 10039073 Rheumatoid arthritis PT
    Population Age: Gender: Male, Female
    Trial protocol: SE (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2007-000293-23 Sponsor Protocol Number: 2007-01 Start Date*: 2007-05-10
    Sponsor Name:Karolinska Universitetssjukhuset i Solna, Thoraxanestesi & intensivvård
    Full Title: Narkosgas jämfört med konventionell intravenös sedering vid respiratorvård efter kranskärlskirurgi.
    Medical condition: Studiegruppen består av kranskärlssjuka patienter som efter genomgången kranskärlskirurgi respiratorvårdas vid thoraxintensivvårdsavdelningen, enligt gängse postoperativ rutin, fram tills att förhå...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10012208 Delayed recovery from anesthesia LLT
    9.1 10006894 CABG LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-005097-19 Sponsor Protocol Number: EVOLVD Start Date*: 2019-01-23
    Sponsor Name:Oslo University Hospital
    Full Title: Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients
    Medical condition: Cardiac allograft vasculopathy in de-novo heart transplant recipients
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NO (Completed) DK (Completed) FI (Completed) SE (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 31 03:08:12 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA